amphetamine has been researched along with sr141716 in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Gueudet, C; Le Fur, G; Rinaldi-Carmona, M; Santucci, V; Soubrié, P | 1 |
| Karoum, F; Masserano, JM; Wyatt, RJ | 1 |
| Burton, P; Mechoulam, R; Parker, LA; Sorge, RE; Yakiwchuk, C | 1 |
| Gessa, GL; Melis, M; Muntoni, AL; Perra, S; Pillolla, G; Pistis, M | 1 |
| Davis, RJ; Degroot, A; Nomikos, GG; Tzavara, ET; Wade, MR | 1 |
| Kõks, S; Matsui, T; Orav, L; Rünkorg, K; Vasar, E; Volke, V | 1 |
| Pattij, T; Schetters, D; Schoffelmeer, AN; Stoop, N; Wiskerke, J | 1 |
| Carroll, FI; McMahon, LR; Schulze, DR | 1 |
| Antoniou, K; Chouliara, O; Galanopoulos, A; Naxakis, G; Papadopoulou-Daifoti, Z; Papahatjis, D; Polissidis, A | 1 |
| Bunner, KD; Cheer, JF; Covey, DP; Garris, PA; Schuweiler, DR | 1 |
| Chen, SF; Chuang, CY; Hsu, WC; Liao, RM; Lu, XY | 1 |
12 other study(ies) available for amphetamine and sr141716
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
The CB1 cannabinoid receptor antagonist SR 141716A affects A9 dopamine neuronal activity in the rat.
Topics: Amphetamine; Animals; Apomorphine; Dopamine; Dopamine Agents; Dopamine Agonists; Electrophysiology; Male; Mesencephalon; Neurons; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Rimonabant | 1995 |
SR 141716A, a CB1 cannabinoid receptor antagonist, potentiates the locomotor stimulant effects of amphetamine and apomorphine.
Topics: Amphetamine; Animals; Apomorphine; Central Nervous System Stimulants; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Synergism; Injections, Intraperitoneal; Male; Motor Activity; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Rimonabant | 1999 |
Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats.
Topics: Amphetamine; Animals; Cannabidiol; Cocaine; Conditioning, Operant; Dronabinol; Extinction, Psychological; Learning; Male; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant | 2004 |
Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons.
Topics: Action Potentials; Age Factors; Amphetamine; Analysis of Variance; Animals; Benzoxazines; Cannabinoids; Cocaine; Critical Period, Psychological; Dopamine; Dose-Response Relationship, Drug; Drug Tolerance; Electrophysiology; Illicit Drugs; Male; Morphine; Morpholines; Naphthalenes; Nerve Net; Neurons; Nucleus Accumbens; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Rimonabant; Ventral Tegmental Area | 2004 |
CB1 receptor knockout mice are hyporesponsive to the behavior-stimulating actions of d-amphetamine: role of mGlu5 receptors.
Topics: Amphetamine; Analysis of Variance; Animals; Behavior, Animal; Dizocilpine Maleate; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Hyperkinesis; Mice; Mice, Inbred C57BL; Mice, Knockout; Microdialysis; Motor Activity; Nucleus Accumbens; Piperidines; Pyrazoles; Pyridines; Receptor, Cannabinoid, CB1; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Rimonabant | 2009 |
Rimonabant attenuates amphetamine sensitisation in a CCK2 receptor-dependent manner.
Topics: Amphetamine; Animals; Behavior, Animal; Cannabinoid Receptor Antagonists; Cannabinoid Receptor Modulators; Central Nervous System Stimulants; Male; Mice; Mice, Knockout; Motor Activity; Piperidines; Pyrazoles; Receptor, Cholecystokinin B; Rimonabant | 2012 |
Cannabinoid CB1 receptor activation mediates the opposing effects of amphetamine on impulsive action and impulsive choice.
Topics: Amphetamine; Animals; Behavior, Animal; Choice Behavior; Dronabinol; Drug Inverse Agonism; Impulsive Behavior; Piperidines; Pyrans; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Reward; Rimonabant | 2011 |
Interactions between dopamine transporter and cannabinoid receptor ligands in rhesus monkeys.
Topics: Amphetamine; Animals; Cocaine; Discrimination Learning; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Dronabinol; Female; Haloperidol; Imipramine; Macaca mulatta; Male; Piperidines; Pyrazoles; Receptors, Cannabinoid; Rimonabant; Tropanes | 2012 |
Cannabinoids negatively modulate striatal glutamate and dopamine release and behavioural output of acute D-amphetamine.
Topics: Amphetamine; Animals; Benzoxazines; Cannabinoid Receptor Antagonists; Cannabinoids; Central Nervous System Stimulants; Corpus Striatum; Dopamine; Drug Therapy, Combination; Glutamic Acid; Male; Microdialysis; Morpholines; Motor Activity; Naphthalenes; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Synaptic Transmission | 2014 |
Amphetamine elevates nucleus accumbens dopamine via an action potential-dependent mechanism that is modulated by endocannabinoids.
Topics: Action Potentials; Amphetamine; Animals; Cannabinoid Receptor Antagonists; Dopamine; Dopamine Agents; Endocannabinoids; Male; Neurons; Nucleus Accumbens; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Sodium Channel Blockers; Tetrodotoxin; Ventral Tegmental Area | 2016 |
Comparative effects of cannabinoid CB1 receptor agonist and antagonist on timing impulsivity induced by d-amphetamine in a differential reinforcement of low-rate response task in male rats.
Topics: Amphetamine; Animals; Cannabinoid Receptor Agonists; Cannabinoids; Central Nervous System Stimulants; Dextroamphetamine; Humans; Impulsive Behavior; Male; Rats; Receptor, Cannabinoid, CB1; Rimonabant | 2022 |